VCYT
Income statement / Annual
Last year (2023), Veracyte, Inc.'s total revenue was $361.05 M,
an increase of 21.76% from the previous year.
In 2023, Veracyte, Inc.'s net income was -$74.40 M.
See Veracyte, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$361.05 M
|
$296.54 M
|
$219.51 M
|
$117.48 M
|
$120.37 M
|
$92.01 M
|
$71.95 M
|
$65.09 M
|
$49.50 M
|
$38.19 M
|
| Cost of Revenue |
$137.90 M |
$101.58 M |
$74.40 M |
$41.46 M |
$36.52 M |
$33.08 M |
$28.20 M |
$25.46 M |
$21.50 M |
$16.61 M |
| Gross Profit |
$223.15 M |
$194.95 M |
$145.11 M |
$76.03 M |
$83.85 M |
$58.93 M |
$43.76 M |
$39.62 M |
$28.01 M |
$21.58 M |
| Gross Profit Ratio |
0.62 |
0.66 |
0.66 |
0.65 |
0.7 |
0.64 |
0.61 |
0.61 |
0.57 |
0.57 |
| Research and Development
Expenses |
$56.37 M
|
$40.60 M
|
$29.84 M
|
$17.20 M
|
$14.85 M
|
$14.82 M
|
$13.88 M
|
$15.32 M
|
$12.80 M
|
$9.80 M
|
| General & Administrative
Expenses |
$157.63 M
|
$76.52 M
|
$101.35 M
|
$36.73 M
|
$29.03 M
|
$23.96 M
|
$23.09 M
|
$23.79 M
|
$22.58 M
|
$18.85 M
|
| Selling & Marketing
Expenses |
$26.60 M
|
$97.56 M
|
$79.84 M
|
$52.39 M
|
$53.69 M
|
$41.31 M
|
$32.26 M
|
$28.25 M
|
$25.29 M
|
$21.93 M
|
| Selling, General &
Administrative Expenses |
$178.85 M
|
$174.08 M
|
$181.19 M
|
$89.12 M
|
$82.72 M
|
$65.28 M
|
$55.35 M
|
$52.04 M
|
$47.88 M
|
$40.79 M
|
| Other Expenses |
$560,000.00 |
$21.35 M |
$15.98 M |
$5.10 M |
$1.40 M |
$1.20 M |
$476,000.00 |
$202,000.00 |
$140,000.00 |
$72,000.00 |
| Operating Expenses |
$235.22 M |
$236.04 M |
$227.02 M |
$111.42 M |
$98.97 M |
$81.16 M |
$70.30 M |
$68.43 M |
$61.47 M |
$50.59 M |
| Cost And Expenses |
$373.11 M |
$337.62 M |
$301.42 M |
$152.87 M |
$135.50 M |
$114.24 M |
$98.49 M |
$93.89 M |
$82.97 M |
$67.20 M |
| Interest Income |
$7.34 M |
$1.97 M |
$135,000.00 |
$594,000.00 |
$2.35 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$15,000.00 |
-$4.65 M |
$241,000.00 |
$229,000.00 |
$677,000.00 |
$1.96 M |
$4.94 M |
$2.76 M |
$378,000.00 |
$439,000.00 |
| Depreciation &
Amortization |
$27.19 M
|
$29.25 M
|
$21.23 M
|
$8.91 M
|
$4.12 M
|
$3.92 M
|
$3.84 M
|
$3.51 M
|
$800,000.00
|
$1.18 M
|
| EBITDA |
$15.13 M
|
-$15.15 M
|
-$62.31 M
|
-$26.74 M
|
-$7.81 M
|
-$17.12 M
|
-$22.22 M
|
-$27.53 M
|
-$32.53 M
|
-$28.93 M
|
| EBITDA Ratio |
0.04 |
-0.05 |
-0.28 |
-0.23 |
-0.06 |
-0.19 |
-0.31 |
-0.42 |
-0.66 |
-0.76 |
| Operating Income Ratio
|
-0.03
|
-0.14
|
-0.37
|
-0.3
|
-0.13
|
-0.24
|
-0.37
|
-0.44
|
-0.68
|
-0.76
|
| Total Other
Income/Expenses Net |
-$64.55 M
|
$4.65 M
|
$254,000.00
|
$480,000.00
|
$2.53 M
|
$1.20 M
|
$476,000.00
|
$202,000.00
|
$140,000.00
|
$72,000.00
|
| Income Before Tax |
-$76.61 M |
-$36.43 M |
-$81.65 M |
-$34.91 M |
-$12.60 M |
-$23.00 M |
-$31.00 M |
-$31.36 M |
-$33.70 M |
-$29.37 M |
| Income Before Tax Ratio
|
-0.21
|
-0.12
|
-0.37
|
-0.3
|
-0.1
|
-0.25
|
-0.43
|
-0.48
|
-0.68
|
-0.77
|
| Income Tax Expense |
-$2.21 M |
$133,000.00 |
-$6.09 M |
$938,000.00 |
$3.88 M |
$1.20 M |
$5.42 M |
$2.96 M |
$518,000.00 |
-$664,000.00 |
| Net Income |
-$74.40 M |
-$36.56 M |
-$75.56 M |
-$35.85 M |
-$16.48 M |
-$23.00 M |
-$31.00 M |
-$31.36 M |
-$33.70 M |
-$29.37 M |
| Net Income Ratio |
-0.21 |
-0.12 |
-0.34 |
-0.31 |
-0.14 |
-0.25 |
-0.43 |
-0.48 |
-0.68 |
-0.77 |
| EPS |
-1.02 |
-0.51 |
-1.11 |
-0.67 |
-0.36 |
-0.62 |
-0.91 |
-1.09 |
-1.3 |
-1.36 |
| EPS Diluted |
-1.02 |
-0.51 |
-1.11 |
-0.67 |
-0.36 |
-0.62 |
-0.91 |
-1.09 |
-1.3 |
-1.36 |
| Weighted Average Shares
Out |
$72.64 M
|
$71.55 M
|
$67.89 M
|
$53.24 M
|
$46.14 M
|
$37.02 M
|
$33.93 M
|
$28.83 M
|
$25.94 M
|
$21.64 M
|
| Weighted Average Shares
Out Diluted |
$72.64 M
|
$71.55 M
|
$67.89 M
|
$53.24 M
|
$46.14 M
|
$37.02 M
|
$33.93 M
|
$28.83 M
|
$25.94 M
|
$21.64 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
